MedTrace Logo

CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer

NCT03012282 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-07-06

No results posted yet for this study

Summary

This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radiation therapy and may help guide treatment for patients with pancreatic cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Computed Tomography Perfusion Imaging

Undergo CT perfusion sequence

Sponsors & Collaborators

Principal Investigators

  • Ryan O'Malley · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-22
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03012282 on ClinicalTrials.gov